Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
24
TLLTF Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
-35.47%
Day range:
$0.0001 - $0.0001
52-week range:
$0.0000 - $0.0340
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.84x
Volume:
--
Avg. volume:
230.3K
1-year change:
-99.98%
Market cap:
$400
Revenue:
$115.6M
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
$28.4M | -- | -23.11% | -- | -- |
|
ATHXQ
Athersys, Inc.
|
-- | -- | -- | -- | -- |
|
ELOX
Eloxx Pharmaceuticals, Inc.
|
-- | -- | -- | -- | -- |
|
INFIQ
Infinity Pharmaceuticals, Inc.
|
-- | -- | -- | -- | -- |
|
MRZM
Marizyme, Inc.
|
-- | -- | -- | -- | -- |
|
SEELQ
Seelos Therapeutics, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
$0.0000 | -- | $400 | -- | $0.00 | 0% | 0.00x |
|
ATHXQ
Athersys, Inc.
|
$0.0000 | -- | $100 | -- | $0.00 | 0% | 0.00x |
|
ELOX
Eloxx Pharmaceuticals, Inc.
|
$0.0001 | -- | $300 | -- | $0.00 | 0% | 0.00x |
|
INFIQ
Infinity Pharmaceuticals, Inc.
|
$0.0000 | -- | $100 | -- | $0.00 | 0% | 0.00x |
|
MRZM
Marizyme, Inc.
|
$0.0000 | -- | $100 | -- | $0.00 | 0% | 0.00x |
|
SEELQ
Seelos Therapeutics, Inc.
|
$0.0000 | -- | -- | -- | $0.00 | 0% | 0.00x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
284.7% | 0.814 | 4240% | 0.06x |
|
ATHXQ
Athersys, Inc.
|
-- | 401.232 | -- | -- |
|
ELOX
Eloxx Pharmaceuticals, Inc.
|
-- | -351.174 | -- | -- |
|
INFIQ
Infinity Pharmaceuticals, Inc.
|
-- | 67.071 | -- | -- |
|
MRZM
Marizyme, Inc.
|
192.4% | 14.269 | 193.54% | 0.00x |
|
SEELQ
Seelos Therapeutics, Inc.
|
-- | 170.665 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
-$2.9M | -$5M | -79.4% | -501.61% | -47.75% | $2.2M |
|
ATHXQ
Athersys, Inc.
|
-- | -- | -- | -- | -- | -- |
|
ELOX
Eloxx Pharmaceuticals, Inc.
|
-- | -- | -- | -- | -- | -- |
|
INFIQ
Infinity Pharmaceuticals, Inc.
|
-- | -- | -- | -- | -- | -- |
|
MRZM
Marizyme, Inc.
|
-- | -$1.6M | -529.96% | -- | -6283.56% | -$732.9K |
|
SEELQ
Seelos Therapeutics, Inc.
|
-- | -- | -- | -- | -- | -- |
TILT Holdings, Inc. vs. Competitors
-
Which has Higher Returns TLLTF or ATHXQ?
Athersys, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Athersys, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M ATHXQAthersys, Inc.-- -- -- -
What do Analysts Say About TLLTF or ATHXQ?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Athersys, Inc. has an analysts' consensus of -- which suggests that it could grow by 549999900%. Given that Athersys, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe Athersys, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 ATHXQAthersys, Inc.0 0 0 -
Is TLLTF or ATHXQ More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Athersys, Inc. has a beta of 50.384, suggesting its more volatile than the S&P 500 by 4938.411%.
-
Which is a Better Dividend Stock TLLTF or ATHXQ?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Athersys, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Athersys, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or ATHXQ?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Athersys, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is higher than Athersys, Inc.'s net income of --. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Athersys, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.00x for Athersys, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M ATHXQAthersys, Inc.0.00x -- -- --
-
Which has Higher Returns TLLTF or ELOX?
Eloxx Pharmaceuticals, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Eloxx Pharmaceuticals, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M ELOXEloxx Pharmaceuticals, Inc.-- -- -- -
What do Analysts Say About TLLTF or ELOX?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Eloxx Pharmaceuticals, Inc. has an analysts' consensus of -- which suggests that it could grow by 29999900%. Given that Eloxx Pharmaceuticals, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe Eloxx Pharmaceuticals, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 ELOXEloxx Pharmaceuticals, Inc.0 0 0 -
Is TLLTF or ELOX More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Eloxx Pharmaceuticals, Inc. has a beta of -76.396, suggesting its less volatile than the S&P 500 by 7739.587%.
-
Which is a Better Dividend Stock TLLTF or ELOX?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Eloxx Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Eloxx Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or ELOX?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Eloxx Pharmaceuticals, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is higher than Eloxx Pharmaceuticals, Inc.'s net income of --. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Eloxx Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.00x for Eloxx Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M ELOXEloxx Pharmaceuticals, Inc.0.00x -- -- --
-
Which has Higher Returns TLLTF or INFIQ?
Infinity Pharmaceuticals, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Infinity Pharmaceuticals, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M INFIQInfinity Pharmaceuticals, Inc.-- -- -- -
What do Analysts Say About TLLTF or INFIQ?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Infinity Pharmaceuticals, Inc. has an analysts' consensus of -- which suggests that it could grow by 29999900%. Given that Infinity Pharmaceuticals, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe Infinity Pharmaceuticals, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 INFIQInfinity Pharmaceuticals, Inc.0 0 0 -
Is TLLTF or INFIQ More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Infinity Pharmaceuticals, Inc. has a beta of 6.447, suggesting its more volatile than the S&P 500 by 544.677%.
-
Which is a Better Dividend Stock TLLTF or INFIQ?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Infinity Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Infinity Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or INFIQ?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Infinity Pharmaceuticals, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is higher than Infinity Pharmaceuticals, Inc.'s net income of --. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Infinity Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.00x for Infinity Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M INFIQInfinity Pharmaceuticals, Inc.0.00x -- -- --
-
Which has Higher Returns TLLTF or MRZM?
Marizyme, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of -18950.82%. TILT Holdings, Inc.'s return on equity of -501.61% beat Marizyme, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M MRZMMarizyme, Inc.70.64% -$0.03 $11.7M -
What do Analysts Say About TLLTF or MRZM?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Marizyme, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that TILT Holdings, Inc. has higher upside potential than Marizyme, Inc., analysts believe TILT Holdings, Inc. is more attractive than Marizyme, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 MRZMMarizyme, Inc.0 0 0 -
Is TLLTF or MRZM More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Marizyme, Inc. has a beta of 0.945, suggesting its less volatile than the S&P 500 by 5.509%.
-
Which is a Better Dividend Stock TLLTF or MRZM?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marizyme, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Marizyme, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or MRZM?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Marizyme, Inc. quarterly revenues of $32.9K. TILT Holdings, Inc.'s net income of -$9.2M is lower than Marizyme, Inc.'s net income of -$4.1M. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Marizyme, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.00x for Marizyme, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M MRZMMarizyme, Inc.0.00x -- $32.9K -$4.1M
-
Which has Higher Returns TLLTF or SEELQ?
Seelos Therapeutics, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Seelos Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M SEELQSeelos Therapeutics, Inc.-- -- -- -
What do Analysts Say About TLLTF or SEELQ?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Seelos Therapeutics, Inc. has an analysts' consensus of -- which suggests that it could grow by 511999900%. Given that Seelos Therapeutics, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe Seelos Therapeutics, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 SEELQSeelos Therapeutics, Inc.0 0 0 -
Is TLLTF or SEELQ More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Seelos Therapeutics, Inc. has a beta of 1.193, suggesting its more volatile than the S&P 500 by 19.317%.
-
Which is a Better Dividend Stock TLLTF or SEELQ?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Seelos Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Seelos Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or SEELQ?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Seelos Therapeutics, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is higher than Seelos Therapeutics, Inc.'s net income of --. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Seelos Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.00x for Seelos Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M SEELQSeelos Therapeutics, Inc.0.00x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
